Publications

Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial

Mayne K. et al, (2024), Nephrology Dialysis Transplantation

Diabetic Kidney Disease - Semaglutide Flows into the Mainstream.

Herrington WG. and Haynes R., (2024), N Engl J Med, 391, 178 - 179

Heart failure events in randomized controlled trials for adults receiving maintenance dialysis: a meta-epidemiologic study.

Collister D. et al, (2024), Nephrol Dial Transplant

Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trial

Mayne K. and HERRINGTON W., (2024), American Society of Nephrology. Clinical Journal

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis.

Cholesterol Treatment Trialists’ (CTT) Collaboration. Electronic address: ctt@ndph.ox.ac.uk None. and Cholesterol Treatment Trialists’ (CTT) Collaboration None., (2024), Lancet Diabetes Endocrinol, 12, 306 - 319

Effects of SGLT2 inhibitors on cause-specific cardiovascular death in patients with chronic kidney disease: a meta-analysis of CKD progression trials.

Fletcher RA. et al, (2024), Clin J Am Soc Nephrol

Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis.

Patel SM. et al, (2024), Circulation

Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns

Levin A. et al, (2024), Kidney International, 105, 684 - 701

KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group None., (2024), Kidney Int, 105, S117 - S314

EFFECTS OF EMPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE FROM JAPAN: EXPLORATORY ANALYSES FROM EMPA-KIDNEY

HERRINGTON W., (2024), Clinical and Experimental Nephrology

[2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes].

Marx N. et al, (2024), G Ital Cardiol (Rome), 25, e1 - e103

Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials

Apperloo EM. et al, (2024), The Lancet Diabetes and Endocrinology

Effects of Empagliflozin on Fluid Overload, Weight and Blood Pressure in Chronic Kidney Disease

Mayne K. et al, (2023), Journal of the American Society of Nephrology

SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA

Mark PB. et al, (2023), Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 38, 2444 - 2455

Effects of empagliflozin on progression of chronic kidney disease: a pre-specified secondary analysis from the EMPA-KIDNEY trial

HAYNES R. et al, (2023), Lancet Diabetes and Endocrinology

Impact of Primary Kidney Disease on the Effects of Empagliflozin in Patients with Chronic Kidney Disease: Secondary Analyses of the EMPA-KIDNEY trial

Judge P. et al, (2023), Lancet Diabetes and Endocrinology

Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis.

Writing Group for the CKD Prognosis Consortium None. et al, (2023), JAMA, 330, 1266 - 1277

UK Kidney Association Clinical Practice Guideline: Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease 2023 UPDATE

HERRINGTON W., (2023), BMC Nephrology

2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.

Marx N. et al, (2023), Eur Heart J

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

LANDRAY M. et al, (2023), Lancet Diabetes and Endocrinology

Cookies on this website

Publications